Medplus Share Price (MEDPLUS)
Check the latest share price of Medplus, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Medplus Stock Performance
Get live Medplus share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹870.45Day's Price Range₹886.2552 Week's Low
52 Week's High
₹61652-Week Price Range₹1,045.3
| Returns % | |
| 1 Month Return | + 7.34 % |
| 3 Month Return | + 25.8 % |
| 1 Year Return | + 26.3 % |
| 3 Year Return | + 23.61 % |
| 5 Year Return | -21.46 % |
| Market Stats | |
| Previous Close | ₹889.20 |
| Open | ₹875.00 |
| Volume | 1.02L |
| Upper Circuit | ₹1,067.00 |
| Lower Circuit | ₹711.40 |
Medplus Fundamentals & Key Indicators
Check Medplus market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹10,540.24 Cr
Return on Equity (ROE)
0.75
PE Ratio (TTM)
69.89
Return on capital employed (ROCE)
1.13
Industry PE ratio
-370.01
Beta (LTM)
0.64
P/B Ratio
7.03
Dividend Yield
0PEG Ratio
9.84
Quarterly Earnings Growth YOY
52.92
EPS (TTM)
5.49
Sector
Retail
Book Value
132.01
Technical Analysis
Neutral
View Technical Analysis
How to invest in Medplus?
Investing in Medplus is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Medplus or MEDPLUS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Medplus or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Medplus with just a few clicks!
Medplus Stock's Interest Amongst Investors
Medplus Valuation
Track how Medplus P/E has moved over time to understand its valuation trends.
Medplus in the last 5 years
Lowest (55.66x)
April 7, 2025
Industry (-370.01x)
June 13, 2025
Today (69.89x)
June 13, 2025
Highest (263.63x)
March 17, 2023
Today’s Price to Earnings Ratio: 69.89x
Medplus Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Medplus.
based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Medplus. Average target price of ₹1064
Source: S&P Global Market Intelligence
Medplus Share Price Target
Get share price movements and forecasts by analysts on Medplus.
Medplus price forecast by 7 analysts
Upside of20.83%
High
₹1180
Target
₹1064.00
Low
₹933
Medplus target price ₹1064, a slight upside of 20.83% compared to current price of ₹880.6. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medplus revenue growth forecast
Expected growth rate Q1, FY2027:36.24%
Forecast
Actual
Including amortisation and stock based compensations
Medplus EPS growth forecast
EPS estimate Q1, FY2027:317.15%
Forecast
Actual
Source: S&P Global Market Intelligence
Medplus Financial Results
Get the annual and quarterly financial summary of Medplus, including revenue, profit, loss and more.
Indices Featuring Medplus Stock
Check stock indices that include Medplus.
Medplus Earnings and Dividends
View detailed summary of the earnings and dividend history of Medplus.
Medplus Health Services Ltd Earnings Results
Medplus Health Services Ltd’s net profit jumped 53.71% since last year same period to ₹51.34Cr in the Q4 2024-2025. On a quarterly growth basis, Medplus Health Services Ltd has generated 11.88% jump in its net profits since last 3-months.
Read More about Earnings Results
Medplus Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medplus.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 40.34% | 0.00 | |
| Foreign Institutions | 15.61% | 0.00 | |
| Mutual Funds | 21.59% | 0.00 | |
| Retail Investors | 17.82% | 0.00 | |
| Others | 4.64% | 0.00 |
Medplus vs Peers
Compare market cap, revenue, PE, and other key metrics of Medplus with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 10,540.24 | -4.29% | 0.54 | 65 | 5,624 | |
| NA | 23.82 | 43.82% | 2.92 | -2 | 16 | |
| BUY | 5,540.92 | 37.57% | 0.95 | 77 | 4,316 | |
| NA | 41.80 | -19.01% | 0.86 | -1,221 | 1,422 | |
| HOLD | 7,773.74 | 1.82% | 0.50 | 19 | 489 |
Medplus News & Key Events
Latest news and events in one place to help you make informed investing decisions in Medplus.
Medplus Health Reports Strong Financial Growth - 03 Jun, 2025
Medplus Health reported consolidated net sales of Rs 1,509.61 crore for March 2025, up 1.28% YoY. Net profit surged 53.72% to Rs 51.34 crore, while EBITDA rose 30.81%. EPS increased to Rs 4.32. The stock has delivered 16.31% returns over the last six months and 31.20% over the past year.MedPlus Explores Quick Commerce Amid Challenges - 30 May, 2025
MedPlus CEO discusses potential entry into quick commerce, emphasizing the balance between fill rate and delivery speed. The company aims to maintain margins while possibly adjusting delivery fees.MedPlus Reports Mixed Q4 Results with Profit Growth - 29 May, 2025
MedPlus Health Services reported a 3.32% sequential decline in Q4 revenue but a 12.01% rise in net profit. Year-on-year, net profit surged 53.7%. The company added 100 new stores, increasing total count to 4,712. For FY25, net profit rose 129.6%.Medplus Health Reports Strong Q4 Results and Expansion Plans - 28 May, 2025
Medplus Health Services reported a 53.7% increase in Q4 profit and a 129.6% rise in full-year net profit. The company plans to open 600 new stores in FY26, contributing to growth. Shares hit a 52-week high amid increased trading volume.
Insights on Medplus Health Services Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 15.23% to 15.61% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, MEDPLUS stock has moved up by 25.8%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 21.51% to 21.59% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 14.36 Cr → 51.34 Cr (in ₹), with an average increase of 29.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Novelix Pharmaceuticals Ltd has given 54.9% return, outperforming this stock by 28.6%
- NO EFFECT
Against Peers
In the last 3 years, Novelix Pharmaceuticals Ltd has given 241.1% return, outperforming this stock by 217.4%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 1.58K Cr → 1.52K Cr (in ₹), with an average decrease of 2.0% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 18.69% to 17.82% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 40.39% to 40.34% in Mar 2025 quarter
About Medplus
The company's retail pharmacy offers an extensive selection of prescription and over-the-counter medicines, including popular brands such as Pfizer, Novartis, and GlaxoSmithKline. It also stocks a wide range of health and wellness products, including vitamins, supplements, and herbal products.
Medplus also offers a variety of healthcare services, including home nursing, physiotherapy, and medical equipment rental. Its diagnostic services include X-ray, ultrasound, and lab tests. The company also provides health check-up packages and health insurance services.
Revenue: ₹1,509.61Cr as on March 2025 (Q4 FY25)
Net Profit: ₹51.32Cr as on March 2025 (Q4 FY25)
Listing date: 23 Dec, 2021
Chairperson Name: GANGADI MADHUKAR REDDY
| Organisation | Medplus Health Services Ltd |
| Industry | Retail |
| CEO | GANGADI MADHUKAR REDDY |
| E-voting on shares | Click here to vote |
Mutual Funds that own Medplus
Check out the Mutual Funds with significant holdings in Medplus.
FAQs
What is Medplus share price today?
Medplus share price today stands at ₹880.6, Open: ₹875, Previous Close: ₹889.2, High: ₹886.25, Low: ₹870.45, 52 Week High: ₹1045.3, 52 Week Low: ₹616.
What is today's traded volume of Medplus?
Today's traded volume of Medplus is 1.02L. Which means that 1.02L shares of Medplus were bought and sold on the stock market during today's trading session.
What is Medplus's market cap today?
Today's market capitalisation of Medplus is ₹10,540.24 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Medplus?
Medplus’s 52 week high is ₹1045.3 and 52 week low is ₹616. The current share price of Medplus is ₹880.6, which is -15.76% down from its 52 week high and 42.95% up from its 52 week low.